SOURCE: digiMedical Solutions, Inc.

June 11, 2008 09:43 ET

digiMedical Solutions, Inc. Enters Into Letter of Intent With Hospital Business Concepts to Sell Harrington's Acquisition's Pharmacy Chain

Company to Release Shareholder Letter on the Future Company Direction Utilizing Their Proprietary Digital Medical Technologies

DALLAS, TX--(Marketwire - June 11, 2008) - digiMedical Solutions, Inc. (PINKSHEETS: DGMS) today announced the Company has entered into a non-binding letter of intent (LOI) to sell Harrington's Acquisition Inc.'s pharmacy chain to Hospital Business Concepts. Harrington's Acquisition Inc. is wholly owned by digiMedical. In preparation for this sale, digiMedical has taken recent steps to ready the affected markets. To reduce operational overhead in the Company's pharmacies without losing market share, digiMedical combined pharmacies. In Dallas, Texas, the Company combined their downtown Dallas pharmacy into the Dallas Forest Park pharmacy. Similarly, digiMedical combined their North Naples, Florida, pharmacy into the downtown Naples pharmacy. With these consolidations, overhead was reduced without impacting market reach. The remaining three Harrington's pharmacy locations in Naples and Ft. Myers, Florida, and Dallas, Texas, will be sold to Hospital Business Concepts pending further due diligence as outlined in the LOI.

digiMedical's Future Focus and their Microsoft-based Digital Medical Technology

digiMedical is only selling the pharmacies and is not selling the Company's proprietary digital medical technologies. digiMedical will release a letter to shareholders shortly detailing the sale of the pharmacies and updating shareholders on the future direction and singular focus of the digital medical technology of the company.

digiMedical Prescription Handling Software

digiMedical Solutions, a Microsoft Partner, with operations in Texas and Florida, has built its own suite of proprietary software to handle prescriptions digitally from the physician's office to the pharmacy, securely and in compliance with all DEA and HIPAA requirements. The suite of software includes digiRX, digiRxStream, digiReauth, digiRxComp, and digiAccounting.

Company Updates and Information

To be added to digiMedical's corporate e-mail list for shareholders and interested investors or to receive information on the company, please send an e-mail to ir@digimedical.com.

About digiMedical Solutions, Inc.™

digiMedical Solutions, Inc.™ (www.digimedical.com) is a pharmacy and medical technology company focused on developing next generation digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that will more closely align the doctor, pharmacist and patient. The company's planned growth will come from three channels: direct marketing of the company's wireless base d-prescription technology to doctors, acquisition of independent pharmacy chains and the sale of certain territories to "market partners" licensed to exploit the digiMedical Solutions™ model. digiMedical Solutions, Inc.™ currently owns and operates five (5) pharmacies located in Texas and Florida. digiMedical Solutions'™ unique business model brings doctor, patients and pharmacies into next generation medical technologies.

Forward-Looking Statement

Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward-Looking Statements may be identified by words including "anticipate," "await," "envision," "foresee," "aim at," "believe," "intends," "estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission for additional information and a presentation of the risks and uncertainties that may affect the company's business and results of operations.

Contact Information